Zanidatamab trials for Breast cancer
All Zanidatamab trials · All Breast cancer trials
7
Recruiting trials
Phase breakdown
Phase 1 2Phase 2 6Phase 3 1
Recruiting trials studying Zanidatamab for Breast cancer
- A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
- A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
- A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
- Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- PRE-ISPY Phase I/II Oncology Platform Program
Common questions
How many trials study Zanidatamab for Breast cancer?
7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.